Dr. Teo Cheng Peng
MBBS (Singapore), M.Med (Int Med), FAMS (Haematology)
Medical Director and Co-Founder

Consultant Haematologist & Physician

Director Cancer Prevention Centre

Dr. Teo Cheng Peng was awarded the Public Service Commission Scholarship by the Singapore Government to study Medicine at the National University of Singapore. He graduated with a Bachelor in Medicine and Surgery in 1984 and was conferred a Master of Medicine (Internal Medicine) three years later. Under another scholarship, Dr. Teo received his advanced training at Royal Marsden Hospital, the leading Cancer Centre in the United Kingdom.

Clinic    :      Parkway Cancer Centre
Website:     www.parkwaycancercentre.com/doctors/dr-teo-cheng-peng/

Dr. Teo Cheng Peng was awarded the Public Service Commission Scholarship by the Singapore Government to study Medicine at the National University of Singapore. He graduated with a Bachelor in Medicine and Surgery in 1984 and was conferred a Master of Medicine (Internal Medicine) three years later. Under another scholarship, Dr. Teo received his advanced training at Royal Marsden Hospital, the leading Cancer Centre in the United Kingdom.

Upon returning, he started the Bone Marrow and Peripheral Blood Stem Cell Transplant program at the National University Hospital. In 1995, he was then recruited to develop the Autologous Stem Cell Transplant program for solid tumours in the Department of Medical Oncology, Singapore General Hospital. After a successful implementation of the clinical program, he continued his career in Gleneagles Hospital, where he continued his work with stem cells in the fields of haematology and medical oncology.

Dr. Teo continued to develop his interest in the field of stem cells and was one of the pioneers in starting an autologous stem cell bank in Singapore. Dr. Teo is the Chairman of Gleneagles Hospital Blood Transfusion Committee. He is also a member of the Singapore Society of Haematology, Singapore Bone Marrow Donor Programme, Singapore Society of Oncology, Society of Transplantation (Singapore), International Society of Haematology and Graft Engineering and the International Society of Haematology.

Dr. Teo is widely published in many peer-reviewed journals and participated at many international conferences. He is presently practicing at the Parkway Cancer Centre and Gleneagles Hospital, and is continuing to develop the Stem Cell Transplant programme there.

Committees & Professional Organisations

Chairman of the Gleneagles Hospital Blood Transfusion Committee
Member of the Singapore Society of Haematology
Member of the Singapore Bone Marrow Donor Programme
Member of the Singapore Society of Oncology
Member of the Society of Transplantation (Singapore)
Member of the International Society of Haematology and Graft Engineering
Member of the International Society of Haematology

Publications

  1. Teo CP, Oh VMS, Kueh YK
    Agranulocytosis and anaemia induced by sulfametopyrazine in sulfametopyrazine – trimethoprim combination. Annals of Academy of Medicine, 1989; 18(3) : 307-310.
  2. Teo CP, Fraser A, Han P
    Diagnosis of leucocyte disorders with an automated haematology counter. Annals of Academy of Medicine, 1989; (18(4) : 363-69.
  3. Teo CP, Kueh YK
    Thrombocytopenia in an acute care hospital. Annals of Academy of Medicine, 1989; 18(4) : 379-381.
  4. Han P, Fung KP, Teo CP, Tam LP
    Alpha thalassemia and beta thalassemia traits : biological difference based on red cell indices and zinc protoporphyrin. Clin. Lab. haematol 1990; 12(2); 169-76
  5. Kueh YK, Wang TL, Teo CP, Tan YO
    Acute Deep Vein Thrombosis in hospital practice. Annals of Academy of Medicine, 1992; 21(3) : 345-348
  6. Tan TKS, Teo CP, K Wong, Lim HL
    Cancer : To tell or not to tell. Singapore Medicine Journal, 1993; 34 : 202-203
  7. Lim HL, Teo CP, P Kuperan, R Suri, Tan YO, Kueh YK
    Multiple Myeloma : The NUH Experience. Singapore Medical Journal 1994; 35 : 371-373
  8. Tiley C, Powles RL, Teo CP, Treleavan J, Findlay M, Hewetson M.
    Treatment of acute graft versus host disease with a murine monoclonal antibody to the IL-2 receptor. Bone Marrow Transplantation, 1991: 7(2) : 151
  9. Powles RL, Treleavan J, Millar J, Gordon-Smith E, Tiley C, Findlay M, Teo CP, Duncombe AS, Robinson G.
    How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease. Bone Marrow Transplantation, 1991; 7(2) : 9-10
  10. Powles RL, Treleavan J, Millar J, Gordon-Smith E, Tiley C, Findlay M, Teo CP, Duncombe AS, Robinson G.
    Human recombinant GM-CSF in allogeneic bone marrow transplantation for leukaemia : a double-blind placebo controlled trial. Bone Marrow Transplantation, 1991 : 7(2) : 85-86
  11. Tiley C, Powles RL, Treleavan J, Catovsky D, Milan S, Teo CP, Catalano J, Mehta J, Shields M, Gupta P, Richards S, Millar J and Gorman C.
    Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation of first remission acute lymphoblastic leukaemia. Bone Marrow Transplantation 1993; 12: 449-455
  12. Teo CP, Lim HL, Kueh YK
    Cost-effectiveness and ease of administration of low molecular weight heparin in deep vein thrombosis. Thrombosis and Haemostasis, 1994; 72(2) : 328-9
  13. K Wong, Lim HL, Teo CP, YO Tan
    Treatment of Acute Promyelocytic Leukaemia in First relapse with All-trans Retinoic Acid. Annals of Academy of Medicine Singapore, 1995; 24 : 177-9
  14. Kuperan P. Teo CP, Chong SM, Liu TC
    Splenic lymphoma with villous lymphocytes – An uncommon cause for lymphocytosis. Singapore Medical Journal 1997; 38(9) : 395-8
  15. Leong SS, Teo CP, Tao M, Ang PT
    Use of Ondansetron in the control of Emesis in Autologous Peripheral Blood Stem Cell Transplants for solid tumours. Singapore Medical Journal 1998; 39(9) : 396-8
  16. Tao M, Teo CP, Ngai J, Ong YW, Ang PT
    Comparison of CD-34 positive cell concentration in peripheral blood, colony-forming granulocyte-macrophage (CFU-GM) and mononuclear (MNC) in leukapheresed product for the prediction of peripheral blood CD34-positive cell yield harvested.
  17. Lim HL, Teo CP, Wong K, Kueh YK
    L-Asparaginase induced intracranial haemorrhage in Acute Lymphoblastic Leukaemia. Singapore Medical Journal 1998; 39(2) : 395-98

Abstracts

  1. Use of maintenance chemotherapy after autologous bone marrow transplantation as treatment of poor risk, first remission acute lymphoblastic leukaemia.
  2. Informing the patient of a malignant disease : The Singapore physician’s attitude. 26th Singapore Malaysia Congress of Medicine 1992
  3. Thrombocytopenia and bleeding problem : Frequency, severity and risk factors in care hospital.
    26th Singapore Malaysia Congress of Medicine 1992
  4. Multiple myeloma : The NUH experience
    26th Singapore Malaysia Congress of Medicine 1992
  5. Treatment of small cell cancer of lung : A Singapore experience.
    26th Singapore Malaysia Congress of Medicine 1992
  6. Bone Marrow Registry : A pilot feasibility study in Singapore.
    27th Singapore Malaysia Congress of Medicine 1993
  7. Use of Intramuscular Ketoprofen to reduce pain during bone marrow examination.
    4th Asean Congress of Rheumatology (Singapore) 1993
  8. Study of Haematopoietic Stem Cells in umbilical Cord Blood as a Potential Source for Bone Marrow Transplant
    3rd Paediatric Scientific Meeting 1993
  9. Cost-effectiveness of low molecular weight heparin (Fraxiparine) in the treatment of deep venous thrombosis.
    1st National Conference of Haematology, Malaysian Society of Haematology 1994
    International Symposium on Thrombosis and LMWH, Pattaya, Thailand 1995
  10. Low dose Fluconazole (200 mg/day) as anti-fungal prophylaxis in bone marrow transplant and peripheral blood stem cell transplant.
    12th Asia Pacific Cancer Conference 1995
  11. Correlation with CD34+, CFU-GM and Mononuclear harvest with G-CSF mobilisation in peripheral stem cell harvest.
    12th Asia Pacific Cancer Conference 1995
  12. Peripheral blood stem cell mobilisation with Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in patients with solid tumours undergoing High-Dose Chemotherapy.
    Chapter of Physicians Meeting, Academy of Medicine, Singapore 1996
    13th Asia Pacific Cancer Congress. November 1996
  13. Nutritional Support in Autologous Peripheral Blood Stem Cell Transplant in Solid Tumours.
    7th Annual Scientific Meeting 1996, Singapore General Hospital.
  14. BMT for Solid tumours : The Singapore General Hospital experience.
    Inaugural Meeting of the Malaysian Oncological Society, June 1996
  15. Comparison of CD 34+ cell Concentration in Peripheral Blood, Colony-Forming Units Granulocyte-Macrophage (CFU-GM) and Mononuclear Cells (MNC) in Leukapheresed product for the prediction of peripheral blood CD34+ cell yield harvested after mobilisation therapy.
    7th Annual Scientific Meeting 1996, Singapore General Hospital
    30th Singapore Malaysian Congress of Medicine 1996
  16. BMT for solid tumours.
    Invited speaker for symposium lecture
    30th Singapore Malaysia Congress of Medicine 1996
  17. Tolerability and toxicities of Autologous Peripheral Blood Stem Cell Transplants for solid tumours in local patients.
    13th Asia Pacific Cancer Congress, November 1996
  18. High-dose Chemotherapy with Peripheral Blood Stem Cell Rescue in Adults with Non-Hodgkin’s lymphoma, Hodgkin’s Disease and Myeloma.
    13th Asia Pacific Cancer Congress, November 1996
  19. Use of Ondansetron in the control of emesis in autologous peripheral blood stem cell transplant for solid tumours.
    13th Asia Pacific Cancer Congress, November 1996
  20. High-dose chemotherapy with peripheral blood stem cell rescue in metastatic breast cancers : Singapore General Hospital Experience.
    13th Asia Pacific Cancer Congress, November 1996
× Chat with us